Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Quality of Life Is Worse at 6-10 Years after Radioactive Iodine Treatment of Graves’ Disease as Compared with Antithyroid Drugs or Surgery
source: Clinical Thyroidology
year: 2019
authors: Sun Y. Lee
summary/abstract:Background:
Graves’ disease is a common cause of hyperthyroidism and may be associated with a negative impact on patients’ quality of life (QoL). It can be accompanied by extrathyroidal complications such as ophthalmopathy, dermopathy, and acropachy. Usual treatment options include antithyroid drugs (ATDs), radioiodine (RAI), or surgery. Previous studies have reported similar general-health QoL with the three treatment methods, but were limited to shorter-term follow up. The current study was conducted to assess long-term QoL in patients with Graves’ disease who have been treated in a routine clinical setting.
Methods:
A cohort of 2916 patients with a new diagnosis of hyperthyroidism between 2003 and 2005 was established from seven centers in southern Sweden. Patients were treated according to usual clinical practice. From this cohort, 1186 patients with Graves’ disease were recruited for the current study 6 to 10 years after the original diagnosis to assess QoL measures. Those with recurrent Graves’ disease were excluded.
DOI: 10.1089/ct.2019;31.144-147
read more
myBinderRelated Content
-
Graves’ Disease Pharmacotherapy in Women of Reproductive AgeGraves' disease is an autoimmune disorde...
-
Robert B. Penne, MD, FACSRobert B. Penne, MD is Chief of the Ocul...
-
Alon Kahana, MD, PhDDr. Alon Kahana is the President of Kaha...
-
A Mild Risk of Neonatal Hyperthyroidism Follows Radioactive Iodine Therapy for Graves’ Disease Prior to PregnancyGraves’ disease is an autoimmune condi...
-
Rebecca S. Sippel, MD, FACSRebecca S. Sippel is a Professor of Surg...
-
Graves’ Disease and Pregnancy PlanningBoth hypothyroidism and hyperthyroidism ...
-
Christina’s Thyroid Eye Disease Journey – Dr. Raymond Douglashttps://www.youtube.com/watch?v=XM3Yq43x...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google